The global diclofenac market was valued at USD 3.99 Billion in 2024, driven by the rising prevalence of chronic pain conditions, such as arthritis and musculoskeletal disorders, across the globe. The market is anticipated to grow at a CAGR of 4.40% during the forecast period of 2025-2034, with the values likely to reach USD 6.14 Billion by 2034.
Base Year
Historical Year
Forecast Year
In September 2024, Mankind Pharma launched Nimulid Strong, a topical analgesic gel and spray with 2X diclofenac concentration, to relieve neck pain. Such innovations are set to drive market growth in the coming years.
The rising availability of generic diclofenac and growing focus on developing diclofenac formulations tailored to individual patients are major market trends.
The increasing number of elderly individuals who suffer from chronic pain and inflammation-related conditions is likely to augment market demand in the forecast period.
Diclofenac is a nonsteroidal anti-inflammatory drug, used to treat pain, inflammation, and stiffness caused by conditions such as arthritis, migraines, and post-surgery. It functions by blocking cyclooxygenase (COX) enzymes, resulting in a decrease in prostaglandin production, and resulting in reduced inflammation and pain. The growing demand for pain relief solutions, especially for arthritis and musculoskeletal disorders, is a key factor fuelling the market growth.
Rising Prevalence of Chronic Pain Conditions to Elevate the Market Value
The rising prevalence of chronic pain conditions, such as arthritis and musculoskeletal disorders, is a key growth driver for the global diclofenac market. In 2022, 18.9% of U.S. adults were diagnosed with arthritis, with higher rates among women and older adults. The versatility of diclofenac in oral, topical, and injectable forms makes it a crucial choice for managing pain across various patient groups, boosting its market growth globally.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Route of Administration
Market Breakup by Indication
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
Segmentation Based on Type to Witness Substantial Growth
Based on the type, the market is divided into prescription and over-the-counter. Over-the-counter diclofenac is expected to dominate the market share due to its easy accessibility and increasing consumer preference for self-care products. Regulatory approvals in major regions have increased the availability of over-the-counter diclofenac, leading to sales across retail and online channels.
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is likely to dominate the market during the forecast period due to the increasing prevalence of arthritis and musculoskeletal disorders. Further, the growth in over-the-counter approvals, increasing healthcare expenditure, and the rising awareness of pain management solutions are contributing to the market expansion in the region.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Pfizer is a global leader in biopharmaceuticals, focusing on the discovery, development, and manufacture of treatments for various conditions, including pain and inflammation. The company offers Arthrotec (Diclofenac/misoprostol), a medication used for managing arthritis and musculoskeletal disorders.
Novartis AG is a global healthcare company focused on developing, manufacturing, and marketing pharmaceutical products. Its product Voltaren® contains diclofenac sodium, a non-steroidal anti-inflammatory drug used to treat issues like rheumatoid arthritis, osteoarthritis, and post-operative pain.
GlaxoSmithKline plc is a British multinational pharmaceutical and biotechnology company headquartered in London. Their Voltaren Arthritis Pain, a diclofenac sodium topical gel, is FDA-approved for over-the-counter use, offering temporary relief for arthritis pain in adults.
Aurobindo Pharma Limited, headquartered in Hyderabad, India, is a global pharmaceutical manufacturer specializing in generics and active pharmaceutical ingredients. In February 2023, the company received FDA approval for its diclofenac sodium topical solution USP, an AB-rated generic for treating osteoarthritis knee pain.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Bayer AG, Glenmark Pharmaceuticals Ltd., Merck KGaA, Abbott, Henan Dongtai Pharmaceutical Co., LTD., and Elam Pharma Pvt. Ltd.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share